ArticleOman medical journal2023
Patients with Down Syndrome and COVID-19 Pneumonia Requiring Ventilatory Support: A Case Series.
Article in Oman medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Down syndrome (DS) is the most common chromosomal abnormality found in humans. In Oman, the birth prevalence of DS is 2.4 in 1000 (about 120 affected births per year). Underlying compromised cardiopulmonary status and intellectual disabilities predispose these patients to be particularly vulnerable to serious respiratory viral infections. They also tend to have exaggerated cytokine storms due to underlying immune dysregulation. We report our experience with three DS patients who contracted COVID-19 pneumonia and were admitted to our intensive care unit where they were successfully managed and discharged. Patients with DS are highly susceptible to serious outcomes due to COVID-19. They should be given top priority in immunization programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.